Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus.
Sy A, McCabe L, Hudson E, Ansari AM, Pedergnana V, Lin SK, Santana S, Fiorino M, Ala A, Stone B, Smith M, Nelson M, Barclay ST, McPherson S, Ryder SD, Collier J, Barnes E, Walker AS, Pett SL, Cooke G; STOP-HCV-1 trial team.
Sy A, et al. Among authors: ala a.
PLoS One. 2023 Jan 23;18(1):e0280551. doi: 10.1371/journal.pone.0280551. eCollection 2023.
PLoS One. 2023.
PMID: 36689413
Free PMC article.